Ali M. Eldeeb
Hamad Medical Corporation(QA)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Long-Term Effects of COVID-19, Respiratory viral infections research, COVID-19 Impact on Reproduction
Most-Cited Works
- → Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary report(2020)37 cited
- → Favipiravir for the treatment of coronavirus disease 2019 pneumonia; a propensity score-matched cohort study(2022)
- → 508. Title Favipiravir for the Treatment of Coronavirus Disease 2019; A Propensity Score Matched Cohort Study(2021)
- → Favipiravir for the Treatment of Coronavirus Disease 2019; a propensity score-matched cohort study(2021)